JPRN-jRCTs031200073
已完成
1 期
The efficacy of anti-IL-4/13 receptor monoclonal antibody on chronic prurigo
Tsuyoshi Namiki0 个研究点目标入组 2 人2020年7月21日
概览
- 阶段
- 1 期
- 干预措施
- 未指定
- 疾病 / 适应症
- chronic prurigo
- 发起方
- Tsuyoshi Namiki
- 入组人数
- 2
- 状态
- 已完成
- 最后更新
- 2年前
概览
简要总结
In this study, two cases were successfully treated with dupilumab. Further research is needed to validate the effectiveness of dupilumab in the treatment of prurigo chronica multiformis.
研究者
入排标准
入选标准
- •1\) a patient with chronic prurigo
- •2\) a patient who was not improved by oral anti\-histamine drug and topical steroid
- •3\) a patient at age 20 or over
- •4\) a patient who fully understand and agree to join this clinical study
- •5\) outpatient
排除标准
- •1\) a patient orally administrated immune suppressants or high\-dose steroid within three months
- •2\) a patient who undergo UV photo therapy
- •3\) a patinet who was treated with anti\-IgE antibody within four months
- •4\) a patient suffering from severe visceral diseases, autoimmune diseases, blood dosorders, and mental disorders
- •5\) a patient who is pregnant or breast\-feed
- •6\) a patinet who is infected with parasite
- •7\) a patient who is sensitive to this medication
- •6\) a patient judged inadequate to this study
结局指标
主要结局
未指定
相似试验
已完成
4 期
Dupilumab for Prevention of Recurrence of CRSwNP After ESSChronic Rhinosinusitis With Nasal PolypsNCT04596189Centre hospitalier de l'Université de Montréal (CHUM)30
招募中
1 期
Neoadjuvant Dupilumab and Cemiplimab in Patients With Early-stage Resectable NSCLCNon-Small Cell Lung CancerNCT06088771Icahn School of Medicine at Mount Sinai21
已完成
4 期
Effects of Interleukin (IL)- 4R-alpha Inhibition on Respiratory Microbiome and Immunologic Correlates in Severe AsthmaAsthmaNCT05036733University of Michigan15
已完成
3 期
Dupilumab in Japanese Patients With Atopic DermatitisAtopic DermatitisNCT04678882Sanofi62
招募中
早期 1 期
Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast CancerLocally Advanced Triple Negative Breast CancerTNBC - Triple-Negative Breast CancerNCT06637306Rima Patel15